Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course.

Larenas-Linnemann, Désirée E; Rodríguez-Monroy, Fernanda

Larenas-Linnemann, Désirée E; Rodríguez-Monroy, Fernanda.

Larenas-Linnemann DE; Médica Sur, Clinical Foundation and Hospital, México D.F., Mexico.
Rodríguez-Monroy F; Médica Sur, Clinical Foundation and Hospital, México D.F., Mexico.

Allergy ; 76(3): 910-914, 2021 03.

Article in English | MEDLINE | ID: covidwho-745719

Subject(s)

COVID-19/prevention & control; Measles-Mumps-Rubella Vaccine/immunology; SARS-CoV-2; Vaccination; Adolescent; Adult; Aged; COVID-19/immunology; Child; Female; Humans; Male; Middle Aged; Prospective Studies

Keywords

COVID-19; MMR vaccine; innate immunity; measles vaccine; prevention

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / Measles-Mumps-Rubella Vaccine / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: English Journal: Allergy Year: 2021 Document Type: Article Affiliation country: All.14584

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google